Xu HP - Search Results

1

The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations.

Lin JH, Lin D, Xu L, Wang Q, Hu HH, Xu HP, He ZY. Lin JH, et al. Among authors: xu l, xu hp. Oncotarget. 2017 Jan 10;8(2):3412-3421. doi: 10.18632/oncotarget.13787. Oncotarget. 2017. PMID: 27926500 Free PMC article.

2

[Advances in treatment of brain metastases from primary non-small cell lung cancer].

Lin G, Xu H, Huang C. Lin G, et al. Zhongguo Fei Ai Za Zhi. 2014 Dec;17(12):877-83. doi: 10.3779/j.issn.1009-3419.2014.12.10. Zhongguo Fei Ai Za Zhi. 2014. PMID: 25539615 Free PMC article. Review. Chinese.

3

[Effect of TRAF6 Downregulation on Malignant Biological Behavior of Lung Cancer Cell Lines].

Lin G, Huang C, Su G, Hu H, Xu H, Huang C. Lin G, et al. Zhongguo Fei Ai Za Zhi. 2015 Nov;18(11):661-7. doi: 10.3779/j.issn.1009-3419.2015.11.01. Zhongguo Fei Ai Za Zhi. 2015. PMID: 26582220 Free PMC article. Chinese.

4

Prognostic significance of PD-L1 expression and tumor infiltrating lymphocyte in surgically resectable non-small cell lung cancer.

Lin G, Fan X, Zhu W, Huang C, Zhuang W, Xu H, Lin X, Hu D, Huang Y, Jiang K, Miao Q, Li C. Lin G, et al. Oncotarget. 2017 Aug 12;8(48):83986-83994. doi: 10.18632/oncotarget.20233. eCollection 2017 Oct 13. Oncotarget. 2017. PMID: 29137398 Free PMC article.

5

Assessment of Concordance between 22C3 and SP142 Immunohistochemistry Assays regarding PD-L1 Expression in Non-Small Cell Lung Cancer.

Xu H, Lin G, Huang C, Zhu W, Miao Q, Fan X, Wu B, Zheng X, Lin X, Jiang K, Hu D, Li C. Xu H, et al. Sci Rep. 2017 Dec 5;7(1):16956. doi: 10.1038/s41598-017-17034-5. Sci Rep. 2017. PMID: 29209070 Free PMC article.

6

Co-expression of NF-κB-p65 and phosphorylated NF-κB-p105 is associated with poor prognosis in surgically resectable non-small cell lung cancer.

Lin G, Li C, Huang C, Zhuang W, Huang Y, Xu H, Miao Q, Hu D. Lin G, et al. J Cell Mol Med. 2018 Mar;22(3):1923-1930. doi: 10.1111/jcmm.13476. Epub 2018 Jan 24. J Cell Mol Med. 2018. PMID: 29363879 Free PMC article.

7

Conformance Assessment of PD-L1 Expression Between Primary Tumour and Nodal Metastases in Non-Small-Cell Lung Cancer.

Xu H, Chen X, Lin D, Zhang J, Li C, Zhang D, Zhang X. Xu H, et al. Onco Targets Ther. 2019 Dec 30;12:11541-11547. doi: 10.2147/OTT.S223643. eCollection 2019. Onco Targets Ther. 2019. PMID: 31920342 Free PMC article.

8

MiR-26a-5p Serves as an Oncogenic MicroRNA in Non-Small Cell Lung Cancer by Targeting FAF1.

Ye MF, Lin D, Li WJ, Xu HP, Zhang J. Ye MF, et al. Among authors: xu hp. Cancer Manag Res. 2020 Aug 11;12:7131-7142. doi: 10.2147/CMAR.S261131. eCollection 2020. Cancer Manag Res. 2020. PMID: 32848467 Free PMC article.

9

LHX6 Affects Erlotinib Resistance and Migration of EGFR-Mutant Non-Small-Cell Lung Cancer HCC827 Cells Through Suppressing Wnt/β-Catenin Signaling.

Wang Q, Liao J, He Z, Su Y, Lin D, Xu L, Xu H, Lin J. Wang Q, et al. Onco Targets Ther. 2020 Oct 28;13:10983-10994. doi: 10.2147/OTT.S258896. eCollection 2020. Onco Targets Ther. 2020. PMID: 33149613 Free PMC article.

10

Immunotherapy efficacy prediction through a feature re-calibrated 2.5D neural network.

Xu H, Li C, Zhang L, Ding Z, Lu T, Hu H. Xu H, et al. Comput Methods Programs Biomed. 2024 Jun;249:108135. doi: 10.1016/j.cmpb.2024.108135. Epub 2024 Mar 18. Comput Methods Programs Biomed. 2024. PMID: 38569256

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

153 results

Search Page